The amino acid sequence is the same compound that Eli Lilly has published, but the research-grade material supplied here is not equivalent to Eli Lilly's investigational drug product, is not produced under the same regulatory framework, and is not a substitute for any clinical trial supply, compounded preparation, or future approved formulation
Additionally, while FOXO4-DRI has been shown to limit chemotoxicity in certain contexts, its overall safety profile in humans requires further research to fully understand all potential side effects
Micronized ingredients help provide faster acting relief
GLP-1 Support brings nutrition tracking, medication logging, customizable reminders, and side effect monitoring together in one place so users have the clarity and consistency to turn their medication into lasting change
Alcohol use disorder: Newer GLP-1 receptor agonists linked to fewer alcohol-related hospitalisations - Vera Health NewsAskConsultDiscoverCalculateSign upSign upLoginLoginDiscover